TECN logo

Tecan Group AG Stock Price

SWX:TECN Community·CHF 1.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

TECN Share Price Performance

CHF 151.20
-112.80 (-42.73%)
57.0% undervalued intrinsic discount
CHF 351.30
Fair Value
CHF 151.20
-112.80 (-42.73%)
60.6% undervalued intrinsic discount
CHF 384.00
Fair Value
Price CHF 151.20
AnalystHighTarget CHF 384.00
AnalystConsensusTarget CHF 215.73
AnalystLowTarget CHF 165.20

TECN Community Narratives

AnalystHighTarget·
Fair Value CHF 351.3 56.2% undervalued intrinsic discount

Lab Automation And Personalized Medicine Will Unlock Secular Opportunities

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value CHF 215.73 28.7% undervalued intrinsic discount

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystLowTarget·
Fair Value CHF 165.2 6.9% undervalued intrinsic discount

Tariffs And Disruptions Will Crush Margins While Cuts Will Help

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent TECN News & Updates

Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet

Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)

Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price

Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price

At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?

Tecan Group AG Key Details

CHF 906.6m

Revenue

CHF 587.6m

Cost of Revenue

CHF 319.0m

Gross Profit

CHF 255.9m

Other Expenses

CHF 63.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.97
Gross Margin
35.19%
Net Profit Margin
6.96%
Debt/Equity Ratio
19.5%

Tecan Group AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet established dividend payer.

1 Risk
3 Rewards

About TECN

Founded
1980
Employees
3000
CEO
Monica Manotas
WebsiteView website
www.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Swiss Market Performance

  • 7 Days: 2.4%
  • 3 Months: 3.0%
  • 1 Year: 3.4%
  • Year to Date: 7.1%
Over the last 7 days, the market has risen 2.4%, driven by gains of 3.4% in the Healthcare sector. The market is up 3.4% over the last 12 months. Earnings are forecast to grow by 11% annually. Market details ›